Inhibitory effects of caffeic acid, a coffee-related organic acid, on the propagation of hepatitis C virus

Japanese Journal of Infectious Diseases

Volumn 68, Issue 4, 2015, Pages 268-275

  Tanida, Isei ^a   Shirasago, Yoshitaka ^a,c   Suzuki, Ryosuke ^b   Abe, Ryo ^c   Wakita, Takaji ^b   Hanada, Kentaro ^a   Fukasawa, Masayoshi ^a  

^a Department of Biochemistry and Cell Biology ^*  (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Caffeic acid; Chlorogenic acid; Coffee; HCV; Hepatocellular carcinoma

Indexed keywords

CAFFEIC ACID; CHLOROGENIC ACID; COFFEE PLANT EXTRACT; GENOMIC RNA; LUCIFERASE; PARA COUMARIC ACID; PLANT EXTRACT; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; CAFFEIC ACID DERIVATIVE; COFFEE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CHEMOLUMINESCENCE; COFFEE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO PROPAGATION; LIVER CANCER CELL LINE; LIVER CELL CARCINOMA; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; RNA TRANSLATION; VIRUS INHIBITION; CELL LINE; CHEMISTRY; DRUG EFFECTS; HEPACIVIRUS; LIVER CELL; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CAFFEIC ACIDS; CELL LINE; COFFEE; HEPACIVIRUS; HEPATOCYTES; HUMANS; VIRUS REPLICATION;

EID: 84937415550     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.JJID.2014.309     Document Type: Article

References (37)

1. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007;13:2436-41.
2. Choo QL, Kuo G, Weiner AJ, et al.IsolationofacDNAclone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244:359-62.
3. Mohd Hanafiah K, Groeger J, Flaxman AD, et al. Global epidemiology of hepatitis C virus infection: new estimates of agespecific antibody to HCV seroprevalence. Hepatology. 2012;57: 1333-42.
4. Gravitz L. Introduction: a smouldering public-health crisis. Nature. 2011;474:S2-4.
5. World Health Organization (WHO). Hepatitis C. Available at . AccessedJune1,2015.
6. Lindenbach BD, Evans MJ, Syder AJ, et al. Complete replication of hepatitis C virus in cell culture. Science. 2005;309:623-6.
7. Zhong J, Gastaminza P, Cheng G, et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA. 2005;102:9294-9.
8. Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med. 2005;11:791-6.
9. Torres DM, Harrison SA. Is it time to write a prescription for coffee? Coffee and liver disease. Gastroenterology. 2013;144: 670-2.
10. Johnson S, Koh WP, Wang R, et al. Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Cancer Causes Control. 2011;22: 503-10.
11. Modi AA, Feld JJ, Park Y, et al. Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology. 2010;51: 201-9.
12. Larsson SC, Wolk A. Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology. 2007;132:1740-5.
13. Bravi F, Bosetti C, Tavani A, et al. Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology. 2007;46:430-5.
14. Inoue M, Yoshimi I, Sobue T, et al. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst. 2005;97:293-300.
15. Bravi F, Bosetti C, Tavani A, et al. Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis. Clin Gastroenterol Hepatol. 2013;11:1413-21.
16. Kuper H, Tzonou A, Kaklamani E, et al. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer. 2000;85:498-502.
17. Montella M, Polesel J, La Vecchia C, et al. Coffee and tea consumption and risk of hepatocellular carcinoma in Italy. Int J Cancer. 2007;120:1555-9.
18. Zani C, Donato F, Chiesa M, et al. Alcohol and coffee drinking and smoking habit among subjects with HCV infection. Dig Liver Dis. 2009;41:599-604.
19. Gelatti U, Covolo L, Franceschini M, et al. Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study. J Hepatol. 2005;42:528-34.
20. Tanaka K, Hara M, Sakamoto T, et al. Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan. Cancer Sci. 2007;98:214-8.
21. Ohfuji S, Fukushima W, Tanaka T, et al. Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A case-control study. Hepatol Res. 2006;36:201-8.
22. Ohishi W, Fujiwara S, Cologne JB, et al. Risk factors for hepatocellular carcinoma in a Japanese population: a nested casecontrol study. Cancer Epidemiol Biomarkers Prev. 2008;17: 846-54.
23. Wakai K, Kurozawa Y, Shibata A, et al. Liver cancer risk, coffee, and hepatitis C virus infection: a nested case-control study in Japan. Br J Cancer. 2007;97:426-8.
24. Shimazu T, Inoue M, Sasazuki S, et al. Coffee consumption and risk of endometrial cancer: a prospective study in Japan. Int J Cancer. 2008;123:2406-10.
25. Kurozawa Y, Ogimoto I, Shibata A, et al. Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer. 2005;93:607-10.
26. Costentin CE, Roudot-Thoraval F, Zafrani ES, et al. Association of caffeine intake and histological features of chronic hepatitis C. J Hepatol. 2010;54:1123-9.
27. Freedman ND, Curto TM, Lindsay KL, et al. Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C. Gastroenterology. 2011;140:1961-9.
28. Freedman ND, Everhart JE, Lindsay KL, et al. Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology. 2009;50:1360-9.
29. Inoue M, Kurahashi N, Iwasaki M, et al. Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Cancer Epidemiol Biomarkers Prev. 2009;18:1746-53.
30. Nardini M, Cirillo E, Natella F, et al. Absorption of phenolic acids in humans after coffee consumption. J Agric Food Chem. 2002;50:5735-41.
31. Shirasago Y, Sekizuka T, Saito K, et al. Isolation and Characterization of A Huh.7.5.1-Derived Cell Clone Highly Permissive to Hepatitis C Virus. Jpn J Infect Dis. 2014;68:81-8.
32. Tanida I, Fukasawa M, Ueno T, et al. Knockdown of autophagyrelated gene decreases the production of infectious hepatitis C virus particles. Autophagy. 2009;5:937-45.
33. Murakami Y, Fukasawa M, Kaneko Y, et al. Selective estrogen receptor modulators inhibit hepatitis C virus infection at multiple steps of the virus life cycle. Microbes Infect. 2013;15:45-55.
34. Wakita T, Wands JR. Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides. In vitro model for selection of target sequence. J Biol Chem. 1994;269:14205-10.
35. Bartosch B, Dubuisson J, Cosset FL. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med. 2003;197:633-42.
36. Renouf M, Guy P, Marmet C, et al. Plasma appearance and correlation between coffee and green tea metabolites in human subjects. Br J Nutr. 2010;104:1635-40.
37. Shen H, Yamashita A, Nakakoshi M, et al. Inhibitory effects of caffeic acid phenethyl ester derivatives on replication of hepatitis C virus. PLoS One. 2013;8:e82299.